Results 31 to 40 of about 7,977 (217)

Giant pubertal prolactinoma: Complete resolution following short term carbegoline treatment [PDF]

, 2016
Prolactinomas are the most common pituitary tumors but rarely seen in adolescent males. There is no indication for surgery both in micro‑ and macro‑adenomas unless an urgent treatment is necessary.
Tuzun, D, Gul, K, Oguz, A, Sahin, M
core   +1 more source

Late presentation of acromegaly in medically controlled prolactinoma patients

Endocrinology, Diabetes & Metabolism Case Reports, 2016
Co-secretion of growth hormone (GH) and prolactin (PRL) from a single pituitary adenoma is common. In fact, up to 25% of patients with acromegaly may have PRL co-secretion.
Ekaterina Manuylova, Laura M Calvi, Catherine Hastings, G Edward Vates, Mahlon D Johnson, William T Cave Jr, Ismat Shafiq   +6 more
doaj   +1 more source

A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas

Indian Journal of Endocrinology and Metabolism, 2021
Cabergoline has long been used in the medical management of prolactin-secreting pituitary adenomas. However, there is contradicting and inadequate evidence on the efficacy of cabergoline in achieving radiological and biochemical remission in prolactinoma.
Rakesh Mishra, Subhas K Konar, Adesh Shrivastava, Pradeep Chouksey, Sumit Raj, Amit Agrawal   +5 more
doaj   +1 more source

Is there an increased cardiovascular risk in patients with prolactinoma? A challenging question

, 2021
Purpose Epicardial adipose tissue thickness (EATT) is considered to be a surrogate for visceral fat and a novel cardiovascular risk indicator. Hyperprolactinemia has been shown to be associated with increased cardiovascular risk.
SÜNBÜL, MURAT, YAVUZ, DİLEK
core   +1 more source

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas

Frontiers in Endocrinology, 2022
BackgroundProlactinoma is the most common type of pituitary tumors, and its resultant tumor occupying and hormone disturbance greatly damage the health of patients.
Kejing Zhu, Kejing Zhu, Kejing Zhu, Kejing Zhu, Xueting Cheng, Shuman Wang, Hong Zhang, Yu Zhang, Xiong Wang, Yonggang Chen, Jinhu Wu   +10 more
doaj   +1 more source

Giant Prolactinomas [PDF]

Neuroendocrinology, 2018
Prolactin-secreting adenomas (prolactinomas) are the most common secreting adenomas of the pituitary. Microprolactinomas (diameter <10 mm) are frequently diagnosed in women, whereas macroprolactinomas (maximum diameter ≥10 mm) are generally seen in men. Most macroprolactinomas measure between 10 and 40 mm.
openaire   +2 more sources

Additional file 1 of The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1

, 2022
Additional file 1: Table S1. Primers used for qRT-PCR in this study. Table S2. The clinical data of 15 prolactinoma patients. Table S3. siRNA used in this study. Table S4. Antibodies used in this study. Table S5.
Jing Guo (102972), Yulou Liu (10705962), Qiuyue Fang (9913857), Yazhuo Zhang (3703210), Dawei Wang (471687), Chuzhong Li (3703216), Yiyuan Chen (2715826), Weiyan Xie (7587713)   +7 more
core   +1 more source

Increased Lipid Levels Improves after Treatment with Cabergolin in Patients with Prolactinoma

Medicine Science, 2015
It has been suggested that hyperprolactinemia may be associated with obesity and dyslipidemia. However it is not fully understood that dyslipidemia is occurs independently or due to obesity.
Mazhar Muslum Tuna, Bercem Aycicek Dogan, Mehtap Navdar Basaran, Ayse Arduc, Dilek Berker, Serdar Guler   +5 more
doaj   +1 more source

Treating prolactinoma and psychosis: medication and cognitive behavioural therapy [PDF]

, 2011
The patient in this case report had two severe medical conditions that require oppositional treatment: prolactinoma and psychosis. A prolactinoma is a benign tumour of the pituitary gland that produces prolactin.
M. Birchwood, Otten, J., Becker, H.E., A. Sutterland, H. Becker, L. de Haan, de Haan, L., Sutterland, A.L., M. van der Gaag, Nieman, D.H., Drent, M.L., M. Drent, van der Gaag, M.; id_orcid, D. Nieman, J. Otten, Birchwood, M.   +15 more
core   +1 more source

Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1

Frontiers in Endocrinology, 2019
Context: Overall, giant prolactinomas are rare tumors (4%), especially those larger than 60 mm (1%). Despite the predominance of macroadenoma documented in multiple endocrine neoplasia type 1 (MEN1)-related prolactinoma, only three giant prolactinoma ...
Naiara C. B. Dantas, Carlos E. L. Soares, Manoel R. A. Martins, Delmar M. Lourenço, Delmar M. Lourenço, Ana R. P. Quidute, Ana R. P. Quidute   +6 more
doaj   +1 more source